BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
0.7505
-0.0095 (-1.25%)
At close: Sep 15, 2026, 4:00 PM EDT
0.7397
-0.0108 (-1.44%)
After-hours: Sep 15, 2026, 5:24 PM EDT
BeyondSpring Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
44
Market Cap
30.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | 1.35M | 1.17M | 650.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 146.62M |
| Aligos Therapeutics | 31.52M |
| Radiopharm Theranostics | 9.34M |
| Kyntra Bio | 4.62M |
| IGC Pharma | 1.11M |
BYSI News
- 12 days ago - BeyondSpring Proxy statement: Proxy filing - Filings
- 12 days ago - BeyondSpring Proxy statement: Proxy filing - Filings
- 15 days ago - BeyondSpring Slides: Investor presentation - Filings
- 4 weeks ago - BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - BeyondSpring Quarterly report: Q2 2026 - Filings
- 4 weeks ago - BeyondSpring Earnings release: Q2 2026 - Filings
- 2 months ago - BeyondSpring Slides: Corporate presentation - Filings
- 3 months ago - BeyondSpring appoints Min Qiu as CEO, Na Li as CFO - TheFly